A detailed history of Cra Financial Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Cra Financial Services, LLC holds 2,308 shares of AMGN stock, worth $607,881. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,308
Previous 2,320 0.52%
Holding current value
$607,881
Previous $724,000 2.62%
% of portfolio
0.14%
Previous 0.15%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$309.38 - $337.38 $3,712 - $4,048
-12 Reduced 0.52%
2,308 $743,000
Q2 2024

Jul 11, 2024

BUY
$262.75 - $319.31 $3,153 - $3,831
12 Added 0.52%
2,320 $724,000
Q1 2024

Apr 17, 2024

SELL
$268.87 - $324.56 $3,495 - $4,219
-13 Reduced 0.56%
2,308 $656,000
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $3,324 - $3,749
13 Added 0.56%
2,321 $668,000
Q3 2023

Oct 13, 2023

BUY
$218.65 - $271.46 $10,495 - $13,030
48 Added 2.12%
2,308 $620,000
Q2 2023

Jul 11, 2023

BUY
$214.27 - $253.37 $4,285 - $5,067
20 Added 0.89%
2,260 $501,000
Q1 2023

Apr 06, 2023

BUY
$225.79 - $275.2 $179,954 - $219,334
797 Added 55.23%
2,240 $541,000
Q4 2022

Jan 24, 2023

BUY
$229.03 - $291.01 $14,886 - $18,915
65 Added 4.72%
1,443 $0
Q3 2022

Oct 21, 2022

SELL
$224.46 - $253.15 $62,175 - $70,122
-277 Reduced 16.74%
1,378 $311,000
Q2 2022

Jul 21, 2022

BUY
$230.71 - $256.74 $105,895 - $117,843
459 Added 38.38%
1,655 $403,000
Q1 2022

Apr 15, 2022

SELL
$219.27 - $242.57 $26,312 - $29,108
-120 Reduced 9.12%
1,196 $289,000
Q4 2021

Jan 20, 2022

BUY
$198.88 - $227.6 $19,888 - $22,760
100 Added 8.22%
1,316 $296,000
Q3 2021

Oct 12, 2021

BUY
$212.27 - $248.7 $63,893 - $74,858
301 Added 32.9%
1,216 $259,000
Q2 2021

Jul 23, 2021

SELL
$233.58 - $259.14 $18,686 - $20,731
-80 Reduced 8.04%
915 $223,000
Q4 2020

Jan 27, 2021

BUY
$216.38 - $257.67 $17,310 - $20,613
80 Added 8.74%
995 $229,000
Q3 2020

Oct 14, 2020

SELL
$234.65 - $260.95 $234 - $260
-1 Reduced 0.11%
915 $233,000
Q2 2020

Jul 22, 2020

SELL
$197.81 - $242.74 $31,649 - $38,838
-160 Reduced 14.87%
916 $216,000
Q1 2020

Apr 14, 2020

BUY
$182.24 - $241.7 $7,289 - $9,668
40 Added 3.86%
1,076 $218,000
Q3 2019

Nov 07, 2019

SELL
$174.11 - $208.62 $57,978 - $69,470
-333 Reduced 24.32%
1,036 $200,000
Q2 2019

Jul 24, 2019

BUY
$166.7 - $195.41 $34,006 - $39,863
204 Added 17.51%
1,369 $253,000
Q1 2019

Apr 15, 2019

BUY
$180.87 - $203.88 $11,213 - $12,640
62 Added 5.62%
1,165 $221,000
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $196,775 - $229,699
1,103 New
1,103 $214,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cra Financial Services, LLC Portfolio

Follow Cra Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cra Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cra Financial Services, LLC with notifications on news.